Similar Search Results

Competition and the efficiency of markets for technology

Allain, Marie-Laure; Henry, Emeric; Kyle, Margaret K. - In: Management science : journal of the Institute for … 62 (2016) 4, pp. 1000-1019

Persistent link: https://www.econbiz.de/10011460538

The risk of de-risking innovation : optimal R&D strategies in ambiguous environments

Drakeman, Donald L.; Oraiopoulos, Nektarios - In: California management review 62 (2020) 3, pp. 42-63

Persistent link: https://www.econbiz.de/10012231363

Strategisches Pharma-Management : konsequente Wertoptimierung des Total-Life-Cycle

Dreger, Christian - 2000

Persistent link: https://www.econbiz.de/10001477869

Risk, duration, and capital budgeting : new evidence on some old questions

Cornell, Bradford - In: The journal of business : B 72 (1999) 2, pp. 183-200

Persistent link: https://www.econbiz.de/10001364030

Portfolio-Methoden zur Bewertung bestehender Technologieplattformen sowie zukünftiger Investitionsprojekte in der Pharma- und Biotechnologie-Industrie

Girg, Ulrike; Pacl, Harald - In: Journal of business economics : JBE 72 (2002) 4, pp. 383-401

Persistent link: https://www.econbiz.de/10001659745

Option framework for the valuation of biopharmaceutical companies

Wörner, Stefan - 2001

Persistent link: https://www.econbiz.de/10001640764

Technological regimes and the evolution of networks of innovators : lessons from biotechnology and pharmaceuticals

Riccaboni, Massimo; Pammolli, Fabio - In: International journal of technology management : IJTM 25 (2003) 3/4, pp. 334-349

Persistent link: https://www.econbiz.de/10001932241

Wertorientierte Ausgestaltung der Kompensationsstruktur von Forschungskooperationen : eine Untersuchung am Beispiel der biopharmazeutischen Industrie

Dahlheim, Christian - 2004 - 1. Aufl.

mit einem attraktiven Partner aus der Pharmaindustrie unter Beweis stellen. Ohne dieses Gütesiegel sind auch die …

Persistent link: https://www.econbiz.de/10002146234

Inter-firm R&D networks in pharmaceutical biotechnology : what determines firm's centrality-based partnering capability?

Krogmann, Yin; Riedel, Nadine; Schwalbe, Ulrich - 2013

This paper analyses the inter-firm R&D network formed in the pharmaceutical biotechnology industry during the 1990s … pharmaceutical biotechnology industry has experienced a significant evolutional change in size and structure during 1991-1998. By … not high implying that the distribution of overall positional advantages in the pharmaceutical biotechnology industry is …

Persistent link: https://www.econbiz.de/10009751604

Radical innovation and network evolution

Phlippen, Sandra; Riccaboni, Massimo - 2007

This paper examines how a radical technological innovation affects alliance formation of firms and subsequent network structures. We use longitudinal data of interfirm R&D collaborations in the biopharmaceutical industry in which a new technological regime is established. Our findings suggest...

Persistent link: https://www.econbiz.de/10011372508